SEROQUEL - 0310-0274-60 - (Quetiapine fumarate)

Alphabetical Index


Drug Information of SEROQUEL

Product NDC: 0310-0274
Proprietary Name: SEROQUEL
Non Proprietary Name: Quetiapine fumarate
Active Ingredient(s): 300    mg/1 & nbsp;   Quetiapine fumarate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of SEROQUEL

Product NDC: 0310-0274
Labeler Name: AstraZeneca Pharmaceuticals LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020639
Marketing Category: NDA
Start Marketing Date: 20001113

Package Information of SEROQUEL

Package NDC: 0310-0274-60
Package Description: 60 TABLET, FILM COATED in 1 BOTTLE (0310-0274-60)

NDC Information of SEROQUEL

NDC Code 0310-0274-60
Proprietary Name SEROQUEL
Package Description 60 TABLET, FILM COATED in 1 BOTTLE (0310-0274-60)
Product NDC 0310-0274
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Quetiapine fumarate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20001113
Marketing Category Name NDA
Labeler Name AstraZeneca Pharmaceuticals LP
Substance Name QUETIAPINE FUMARATE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Atypical Antipsychotic [EPC]

Complete Information of SEROQUEL


General Information